Includes the barriers (tariff and non-tariff) that U.S. companies face when exporting to this country.
On January 1, 2009, the government adopted a law banning imported generic pharmaceutical drugs and medical supplies for which adequate amounts of equivalents are produced in Algeria. While this presents a market access barrier for American manufacturers of generic medicines, the ban does not include non-generics and is not a market access barrier for firms with patent-protected drugs. For a list of prohibited products, most recently updated in 2015, please contact the Department of Commerce Desk Officer Arica Young at 202-482-6219; Arica.Young@trade.gov.
In addition to the trade barriers above, Algeria applies a value-added tax (VAT) to the sales of most goods, and VAT rates range from 7 to 19 percent, depending on the product.